Martijn V Verhagen1, Valentina Trevisan2, John Adu3, Catherine M Owens3, Claire Booth2, Alistair Calder4. 1. Department of Paediatric Radiology, Great Ormond Street Hospital for Children, Great Ormond Street, London, WC1N 3JH, UK. m.verhagen@umcg.nl. 2. Department of Paediatric Immunology, Great Ormond Street Hospital for Children, Great Ormond Street, London, WC1N 3JH, UK. 3. Department of Paediatric Radiology, Great Ormond Street Hospital for Children, Great Ormond Street, London, WC1N 3JH, UK. 4. Department of Paediatric Radiology, Great Ormond Street Hospital for Children, Great Ormond Street, London, WC1N 3JH, UK. Alistair.calder@gosh.nhs.uk.
Abstract
PURPOSE: Early differentiation of adenosine deaminase deficient severe combined immunodeficiency (ADA-SCID) from other forms of SCID may initiate appropriate treatment interventions with the aim of metabolic detoxification and improved outcome. Our hypothesis was that previously described radiological features (inferior scapular angle squaring and spurring and costochondral cupping) can differentiate ADA-SCID from other forms of SCID. METHODS: Chest radiographs at clinical presentation between 2000 and 2017 of children with ADA-SCID were retrospectively included, provided that the radiological features were assessable. Random chest radiographs of children with other forms of SCID were included for comparison. Three paediatric radiologists (2 senior, 1 junior) assessed the radiographs for the specific radiological features and stated their diagnosis (ADA-SCID or non-ADA-SCID). An optimal threshold for test performance was defined using a ROC curve. RESULTS: Thirty-six patients with ADA-SCID and twenty-five patients with non-ADA-SCID were included (median age 3.8 months). The optimal threshold for test performance was at approximately < 7 months old: sensitivity 91.7%, specificity 80.7%, interreader agreement was k = 0.709, AUC 0.862. The positive likelihood ratio for scapular squaring, scapular spur, and costochondral cupping was 4.0, 54.6 and 7.8, respectively. The test was valid when performed by both senior and junior paediatric radiologists. CONCLUSION: Radiological features such as scapular spurring, scapular squaring and costochondral cupping can reliably differentiate between ADA-SCID and other forms of SCID. This is true for children aged approximately < 7 months, and this is reliable when assessed by both senior and junior paediatric radiologists.
PURPOSE: Early differentiation of adenosine deaminasedeficient severe combined immunodeficiency (ADA-SCID) from other forms of SCID may initiate appropriate treatment interventions with the aim of metabolic detoxification and improved outcome. Our hypothesis was that previously described radiological features (inferior scapular angle squaring and spurring and costochondral cupping) can differentiate ADA-SCID from other forms of SCID. METHODS: Chest radiographs at clinical presentation between 2000 and 2017 of children with ADA-SCID were retrospectively included, provided that the radiological features were assessable. Random chest radiographs of children with other forms of SCID were included for comparison. Three paediatric radiologists (2 senior, 1 junior) assessed the radiographs for the specific radiological features and stated their diagnosis (ADA-SCID or non-ADA-SCID). An optimal threshold for test performance was defined using a ROC curve. RESULTS: Thirty-six patients with ADA-SCID and twenty-five patients with non-ADA-SCID were included (median age 3.8 months). The optimal threshold for test performance was at approximately < 7 months old: sensitivity 91.7%, specificity 80.7%, interreader agreement was k = 0.709, AUC 0.862. The positive likelihood ratio for scapular squaring, scapular spur, and costochondral cupping was 4.0, 54.6 and 7.8, respectively. The test was valid when performed by both senior and junior paediatric radiologists. CONCLUSION: Radiological features such as scapular spurring, scapular squaring and costochondral cupping can reliably differentiate between ADA-SCID and other forms of SCID. This is true for children aged approximately < 7 months, and this is reliable when assessed by both senior and junior paediatric radiologists.
Authors: Kathryn L Bradford; Federico A Moretti; Denise A Carbonaro-Sarracino; Hubert B Gaspar; Donald B Kohn Journal: J Clin Immunol Date: 2017-08-25 Impact factor: 8.317
Authors: H Bobby Gaspar; Alessandro Aiuti; Fulvio Porta; Fabio Candotti; Michael S Hershfield; Luigi D Notarangelo Journal: Blood Date: 2009-07-28 Impact factor: 22.113
Authors: Donald B Kohn; Michael S Hershfield; Jennifer M Puck; Alessandro Aiuti; Annaliesse Blincoe; H Bobby Gaspar; Luigi D Notarangelo; Eyal Grunebaum Journal: J Allergy Clin Immunol Date: 2018-09-05 Impact factor: 10.793
Authors: Jose A Rodriguez; Tami J Bang; Carlos S Restrepo; Daniel B Green; Lorna P Browne; Daniel Vargas Journal: Radiol Cardiothorac Imaging Date: 2021-03-25
Authors: H Bobby Gaspar; Claire Booth; Alexandra Y Kreins; Helena F Velasco; Kai-Ning Cheong; Kanchan Rao; Paul Veys; Austen Worth Journal: J Clin Immunol Date: 2021-10-16 Impact factor: 8.317